NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/02/2025
Back to search
Official data from USPTO
PURAPHARM ONCO-Z
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PURAPHARM ONCO-Z
ST13
US500000098045875Class
5
Filing
98045875
Registration
7924439
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
09/02/2025
Trademark type
Word
Nice classes
5
Filing date
06/16/2023
Registration date
09/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/02/2025
Last transaction
09/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
77
Owner location
Tai Po, NT, HK
Examiner
BHANOT, KAPIL KUMAR
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PuraPharm International (H.K.) Limited
Representatives
Haverly MacArthur ADAMS AND REESE LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and medical and veterinary preparations for strengthening the immune system and restoring normal bodily functions; pharmaceutical preparations and medical and veterinary preparations for the treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorders and obesity; pharmaceutical preparations and medical and veterinary preparations for central nervous system diseases and disordersbrain diseasescognitive disordersmovement disordersocular motility; pharmaceutical preparations and medical and veterinary preparations for respiratory diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for excretory diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for cardiovascular diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for reproductive diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for endocrinal diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for immunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitis; pharmaceutical preparations and medical and veterinary preparations for dermatological diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for bone diseasesback painmuscular dystrophy and inflammatory muscle diseases; pharmaceutical preparations and medical and veterinary preparations for blindness; sanitary preparations for medical purposes and for personal hygieneother than toiletries; dietetic food and substances adapted for medical or and veterinary use; food for babies; dietary supplements for human beings and animals; plasters for medical purposes; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; nutritional supplements; Chinese patent medicinesherbal medicines for the treatment of tumors and for enhancing the immune system; herbal supplementslingzhi; herbal supplementsyunzhi; herbal supplements in the form of granulespillscapsules and tablets containing yunzhi for the treatment of cancer and cancer affections; herbal supplements in the form of granulespillscapsules and tablets containing lingzhi for the treatment of cancer and cancer affections; herbal supplements containing yunzhi (corioulus versicolor) in the form of capsulesgranulespills and tablets for the treatment of tumors and for enhancing the immune system
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/15/2025
PUBO
PUBLISHED FOR OPPOSITION
07/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2025
ALIE
ASSIGNED TO LIE
06/02/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/20/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/06/2025
GNSL
LETTER OF SUSPENSION E-MAILED
03/06/2025
CNSL
SUSPENSION LETTER WRITTEN
03/06/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/06/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/08/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/08/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/08/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/08/2024
DOCK
ASSIGNED TO EXAMINER
03/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2023
NWAP
NEW APPLICATION ENTERED
06/20/2023
Continuous trademark protection
Get notified about every new filing that threatens PURAPHARM ONCO-Z or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.